Joon-Tae Park

2PUBLICATIONS
25CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 06, 2025
Cholesterol-Lowering Effects of BMS-303141 Analogues via Inhibition of Adenosine Triphosphate-Citrate Lyase.

In-Gyu Je, Joon-Tae Park, Hyeong Jun Lee

|Feb 22, 2023
Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety.

Myongjae Lee, In-Gyu Je, Jeong Eun Kim

Pageof 1